Target Name: LOC105370174
NCBI ID: G105370174
Review Report on LOC105370174 Target / Biomarker Content of Review Report on LOC105370174 Target / Biomarker
LOC105370174
Other Name(s): LOC105370174 variant X1 | uncharacterized LOC105370174 | Uncharacterized LOC105370174, transcript variant X1

LOC105370174 plays role in cellular stress responses

LOC105370174 (LOC105370174 variant X1) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and muscle. It is a member of the heat shock protein (HSP) family, which are proteins that are involved in the regulation of protein synthesis and turnover in response to changes in cellular stress.

The HSP protein is a family of transmembrane or cytoplasmic proteins that can be divided into two distinct types: HSP70 and HSP90. HSP70s are involved in protein-protein interactions and can functions as either chaperones or substrates for various enzymes, while HSP90s are involved in protein-protein interactions and can serve as scaffolds.

LOC105370174 (LOC105370174 variant X1) is a HSP70 protein that is expressed in various tissues of the body, including the brain, heart, liver, and muscle. It is a full-length protein with a calculated molecular weight of 40.1 kDa. LOC105370174 (LOC105370174 variant X1) is expressed in the brain, where it is found in the endoplasmic reticulum (ER) and the cytoplasm.

LOC105370174 (LOC105370174 variant X1) has been shown to play a role in the regulation of cellular stress responses. It has been shown to interact with various cellular signaling pathways, including the NF-kappa pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases, including cancer.

LOC105370174 (LOC105370174 variant X1) has also been shown to interact with stress-responsive transcription factors, such as ATF-1 and NF-kappa-B. These transcription factors are involved in the regulation of cellular stress responses and are key factors in the development and progression of many diseases.

LOC105370174 (LOC105370174 variant X1) has been shown to play a role in the regulation of protein synthesis and turnover in response to changes in cellular stress. It has been shown to interact with various cellular signaling pathways, including the NF-kappa pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases, including cancer.

LOC105370174 (LOC105370174 variant X1) has also been shown to interact with stress-responsive transcription factors, such as ATF-1 and NF-kappa-B. These transcription factors are involved in the regulation of cellular stress responses and are key factors in the development and progression of many diseases.

In conclusion, LOC105370174 (LOC105370174 variant X1) is a protein that is involved in the regulation of cellular stress responses. It has been shown to interact with various cellular signaling pathways, including the NF-kappa pathway, and has been shown to play a role in the regulation of protein synthesis and turnover in response to changes in cellular stress. Further research is needed to fully understand the role of LOC105370174 (LOC105370174 variant X1) in the development and progression of diseases.

Protein Name: Uncharacterized LOC105370174

The "LOC105370174 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105370174 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105370176 | LOC105370182 | LOC105370204 | LOC105370214 | LOC105370222 | LOC105370243 | LOC105370259 | LOC105370262 | LOC105370273 | LOC105370275 | LOC105370286 | LOC105370302 | LOC105370311 | LOC105370312 | LOC105370321 | LOC105370324 | LOC105370328 | LOC105370355 | LOC105370359 | LOC105370384 | LOC105370399 | LOC105370420 | LOC105370429 | LOC105370438 | LOC105370452 | LOC105370455 | LOC105370470 | LOC105370476 | LOC105370481 | LOC105370497 | LOC105370500 | LOC105370504 | LOC105370507 | LOC105370519 | LOC105370529 | LOC105370536 | LOC105370544 | LOC105370546 | LOC105370547 | LOC105370548 | LOC105370549 | LOC105370557 | LOC105370572 | LOC105370574 | LOC105370575 | LOC105370577 | LOC105370579 | LOC105370582 | LOC105370614 | LOC105370616 | LOC105370617 | LOC105370619 | LOC105370627 | LOC105370645 | LOC105370660 | LOC105370706 | LOC105370721 | LOC105370740 | LOC105370819 | LOC105370826 | LOC105370832 | LOC105370834 | LOC105370841 | LOC105370842 | LOC105370843 | LOC105370844 | LOC105370845 | LOC105370846 | LOC105370852 | LOC105370878 | LOC105370891 | LOC105370892 | LOC105370905 | LOC105370906 | LOC105370913 | LOC105370914 | LOC105370941 | LOC105370955 | LOC105370965 | LOC105370978 | LOC105370980 | LOC105370982 | LOC105370988 | LOC105370991 | LOC105370995 | LOC105371002 | LOC105371006 | LOC105371060 | LOC105371061 | LOC105371068 | LOC105371069 | LOC105371072 | LOC105371081 | LOC105371082 | LOC105371097 | LOC105371114 | LOC105371116 | LOC105371160 | LOC105371164 | LOC105371230